Paclitaxel-Eluting Balloons or Everolimus-Eluting Stents for In-Stent Restenosis

JACC Cardiovasc Interv. 2018 Mar 12;11(5):505-506. doi: 10.1016/j.jcin.2017.11.032.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Coronary Restenosis*
  • Drug-Eluting Stents*
  • Everolimus
  • Humans
  • Paclitaxel
  • Stents

Substances

  • Everolimus
  • Paclitaxel